Small Molecules
10 December 2013
Updated Data with Oral Proteasome Inhibitor MLN9708 Reported in Newly Diagnosed Multiple Myeloma Patients10 December 2013
Novartis drug Jakavi® improved overall survival of patients with myelofibrosis in four separate analyses of long-term Phase III studies10 December 2013
Positive Results Presented from Proof-of-Concept Phase II Clinical Trial of Incyte’s Oral JAK1 Inhibitor in Patients with Myelofibrosis9 December 2013
Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophre9 December 2013
True North Therapeutics Presents Preclinical Results Showing Potential of TNT009 to Treat Complement-Mediated Rare Diseases9 December 2013
Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent Non-Hodgkin’s Lymphoma9 December 2013
New five-year data support superiority of Novartis drug Tasigna® over Glivec® in newly diagnosed Ph+ CML patients8 December 2013
Infinity Reports Updated Phase 1 Data of IPI-145 in Indolent Non-Hodgkin Lymphoma at ASH Annual Meeting8 December 2013
Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia7 December 2013
U.S. Food and Drug Administration Approves Gilead’s Sovaldi™ (Sofosbuvir) for the Treatment of Chronic Hepatitis C7 December 2013
GSK and Theravance Announce Positive Results From Pivotal Phase III Study for Fluticasone Furoate/Vilanterol in Asthma6 December 2013
Safinamide Marketing Authorization Application (MAA) submitted to the European Medicines Agency (EMA)6 December 2013
Novartis investigational compound LBH589 significantly extended time without disease progression in Phase III multiple myeloma study5 December 2013
Catabasis Initiates Phase 2 Trial of CAT-2003 in Patients with Severe HypertriglyceridemiaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports